Search Results for “artificial intelligence” – media

Artificial Intelligence Test Determines Risk of Bowel Cancer Recurrence After Surgery

Bowel cancer, commonly referred to as colorectal cancer, can develop anywhere in the large bowel, including the colon and rectum. It ranks among the most prevalent cancers globally, with 1.9 million new cases recorded in 2020. The current protocols for determining the need for chemotherapy for patients with early-stage bowel cancer are not consistently reliable. As a result, some patients receive chemotherapy unnecessarily, while others who might benefit from it do not receive it and may face cancer recurrence. This decision is particularly challenging for stage II colon cancer, where the risk of recurrence post-surgery is generally lower. Now, a new artificial intelligence (AI) test can predict the risk of recurrence in bowel cancers, potentially helping patients avoid unnecessary chemotherapy. This test employs an AI algorithm to measure the concentration of immune cells known as CD3 in tumors at the early stages of bowel cancer. Previous studies have indicated that ...
- Source: drugdu
- 65
- August 5, 2024
Artificial Intelligence workplan to guide use of AI in medicines regulation

EMA and the Heads of Medicines Agencies (HMAs) have published an Artificial Intelligence (AI) workplan to 2028, setting out a collaborative and coordinated strategy to maximise the benefits of AI to stakeholders while managing the risks. The workplan will help the European medicines regulatory network (EMRN) to embrace the opportunities of AI for personal productivity, automating processes and systems, increasing insights into data and supporting more robust decision-making to benefit public and animal health. The AI workplan, prepared under the joint HMA-EMA Big Data Steering Group (BDSG), ensures the EMRN remains at the forefront in benefiting from AI in medicines regulation. The workplan was adopted by EMA’s Management Board at its December meeting. The field of AI is developing swiftly. Pharmaceutical companies increasingly use AI-powered tools in research, development and monitoring of medicines. National competent authorities are responding to the new opportunities and challenges by starting to use and develop ...
- Source: drugdu
- 100
- December 20, 2023
A new antibiotic, discovered with artificial intelligence, may defeat a dangerous superbug

Using artificial intelligence, researchers say, they’ve found a new type of antibiotic that works against a particularly menacing drug-resistant bacteria. When they tested the antibiotic on the skin of mice that were experimentally infected with the superbug, it controlled the growth of the bacteria, suggesting that the method could be used to create antibiotics tailored to fight other drug-resistant pathogens. What’s more, the compound identified by AI worked in a way that stymied only the problem pathogen. It didn’t seem to kill the many other species of beneficial bacteria that live in the gut or on the skin, making it a rare narrowly targeted agent. If more antibiotics worked this precisely, the researchers said, it could prevent bacteria from becoming resistant in the first place. The study was published in the journal Nature Chemical Biology. “It’s incredibly promising,” said Dr. Cesar de la Fuente, an assistant professor at the University of Pennsylvania’s ...
- Source: CNN
- 135
- May 28, 2023
Artificial Intelligence Tracks Eyes to Predict Your Personality

New research by the University of South Australia in partnership with the University of Stuttgart, Flinders University and the Max Planck Institute for Informatics in Germany have developed hi-tech machine-learning algorithms to reveal a connection between personality and eye movements.
- Source: ScienceDaily
- 570
- July 31, 2018
AI digital health Researches
Intel Survey that Supports Artificial Intelligence in Healthcare Settings

A recent survey from Intel revealed that health system decision-makers have considered artificial intelligence as a new element of life. Still, many people are anxious as to whether it could provide safe care.
- Source: Healthcare IT
- 625
- July 10, 2018
AI Market Views
Artificial Intelligence to change Imaging Healthcare

Mark Michalski, MD, executive director of the Massachusetts General Hospital and Brigham and Women's Hospital Center for Clinical Data Science stated that the anticipation regarding AI is due to three key factors: the increasing contribution of digital data that can be created, the creation of algorithms that make artificial neural networks and "GPU" chip architecture (graphics processing unit), developed by NVIDIA.
- Source: HealthIT News
- 669
- June 7, 2018
AI healthcare Researches
Artificial intelligence firm twoXAR raises $10M for partnering drive

Artificial intelligence company twoXAR—a specialist in separating signals from noise in data-rich drug discovery projects—has raised $10 million in a first-round financing led by SoftBank Ventures.
- Source: Fiercebiotech
- 574
- March 22, 2018
diabetes financing Market Views
Artificial Intelligence powers new lung health app

Aseptika in St Ives and Zenzium in Cheshire have been awarded an unspecified grant from the UK’s innovation agency to leverage AI and develop a new home-based early warning system for people with severe respiratory disease.
- Source: Business Weekly
- 620
- March 19, 2018
AI COPD Researches respiratory
J&J CIO touches on FDA pre-cert pilot program, artificial intelligence and innovation

Stuart McGuigan took on his role as CIO of industry behemoth Johnson & Johnson in 2012. That was around the same time that Alex Gorsky joined the company as CEO. Since then, part of Gorsky’s mission has been to help J&J focus on technology, McGuigan said in an interview at HIMSS this week.
- Source: MedCityNews
- 681
- March 9, 2018
AI Company Insight healthcare technologies and innovations
Paige.AI Created to Transform Cancer Diagnosis and Treatment by Applying Artificial Intelligence to Pathology

Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial intelligence (AI), launches today as it announces two major milestones
- Source: tmcnet
- 562
- February 9, 2018
AI Market Views Series

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.